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Abstract 
The fluoroquinoloneantibiotic has been used in clinical practice since the 1980s, primarily for the treatment 
infections caused by Gram-negative bacteria. Moxifloxacin, a fourth-generation fluoroquinolone antibiotic developed 
by pharmaceutical company Bayer AG, exhibit broad spectrum of activity against Gram-negative, Gram-positive 
bacteria as well as  anaerobia. Moxifloxacin is used for community-acquired respiratory tract infections, sinusitis, acute 
exacerbations of chronic bronchitis and pneumonia, and skin structure infections. We have described the synthesis of 
moxifloxacin using difluoroboron complex. In this paper, a practical synthesis of moxifloxacin using acetoxyboronate 
complexwas reported. 
Keywords.Fluoroquinolone, antibiotic, moxifloxacin. 
 
 
1. INTRODUCTION 
 
The fluoroquinoloneantibiotic have been used in 
clinical practice since the 1980s, primarily for the 
treatment infections caused by Gram-negative 
bacteria [1]. Recently, new fluoroquinolone 
derivatives have been developed with enhanced 
activity against Gram-positive microbes as well as 
anaerobia. 
Moxifloxacin, a fourth generation 
fluoroquinolone antibiotic developed by 
pharmaceutical company Bayer AG, reached the 
market in 1999 under brand name Avelox [2]. FDA 
approved Moxifloxacin for the treatment of 
community-acquired respiratory tract infections, 
sinusitis, chronic bronchitis and pneumonia, and 
skin structure infections. In addition, Moxifloxacin 
has been used in clinical for multi-drug resistance 
tuberculosis [3]. 
 
 
We have reported the synthesis of 
fluoroquinolonering and the side chain amine [4-5]. 
The synthesis of Moxifloxacin using difluoroboron 
complex was described [6]. In this study, we 
reported a practical synthesis of moxifloxacin via 
acetoxyboronate complex. In this reaction, the side 
chain amine reacted with the complex  
regioselectively and Moxifloxacin was obtained with 
better yield compared to the previous synthetic 
route. 
 
2. MATERIALS AND METHODS 
 
      All chemicals were used as received from 
commercial sources without further purification. 
Melting point were recorded on a EZ-Melt 
thermometer.
1
H and 
13
C-NMR spectra were 
recorded on a BrukerAvance 500 (500 MHz, 
1
H; 125 
MHz 
13C) spectrometer. The chemical shifts (δ) are 
reported in parts per million (ppm) relative to 
tetramethylsilane (TMS) or the internal solvent 
signal of deuterated solvents (
13
C and 
1
H). 
Multiplicities are indicated by s (singlet), d 
(doublet), t (triplet), m (multiplet) and dd (double 
doublet). Coupling constants J are reported in Hertz. 
The mass spectra were recorded with a Agilent 1260 
MS instrument. For thin layer chromatography, 
analytical TLC plates (70-230 mesh silica gel 
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(Merck) were used. Visualization was accomplished 
with UV (254 nm). 
 
Preparation of complex 2: 1-Cycloropyl-6,7-
difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline 
carboxylic acid-(O
3
, O
4
)-bis-(Acyloxy-O)borate. 
The mixture of boric acid (15 g, 0.24 mol) and 
acetic anhydride (160 mL) was heated to 80
o
C for 1 
hour and then was cooled down to about 60-70 
o
C. 
Ethyll-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-
1,4-dihydro-3-quinoline carboxylate (50 g, 0.155 
mol) is added under stirring. The temperature is then 
raised and maintained for 1 hour in the range of 
100
o
Cto 105
o
C. Chilled water (500 ml) is added and 
the reaction mixture was maintained for 2 hrs at 
0
o
Cto 5
o
C. The boron acetate complex was filtered, 
washed with water (500 ml) and dried at 50 
o
Cto 
55
o
Cunder vacuum to constant weight. The dry 
weight is 63 g corresponding to yield of 96%. 
White powder; mp: 113-114
o
C; 
1
H-NMR 
(500MHz, CDCl3) δ (ppm): 9.19 (s, 1H, H-2); 8.07 
(t, J = 9 Hz, 1H, H-5); 4.37 (m, 1H, CH-N); 4.19 (s, 
3H, OCH3); 2.01 (s, 6H, CH3),  1.29-1.27 (m, 2H, 
CH2-cyclopropyl); 1.21(m, 2H, CH2-cyclopropyl).
 
13
C-NMR (125MHz, CDCl3) δ (ppm): 172.9; 172.9; 
170.3; 153.7; 151.5 (C-F, J = 125 Hz); 150.4; 149.2 
(C-F, J = 125 Hz); 141.5, 133.3; 119.5; 109.0; 
107.2; 63.4; 43.3; 23.0; 9.4; 9.4. ESI-MS m/z: 
[M+H]
+
: 424. 
Synthesis of Moxifloxacin 3: The acetoxyboronate 
complex 2 (50.0 g, 0.118 mol) was suspended in 
solvent (200 ml). (S,S)-2,8-diazabicyclo-(4,3,0)-
nonane (16.3 g, 0.13 mol) diluted with 50 ml solvent 
was slowly added followed by triethylamine (24.5 
ml, 0.177 mol). The reaction mixture were stirred at 
certain temperature. After reaction was over, solvent 
was removed and methanol (200.0 ml) was added. 
pH was adjusted to 1.0-2.0 using hydrochloric acid 
and the reaction mixture was stirred at 10-15 
o
C for 
2 hours. After the completion of the reaction, the 
mixture was concentrated to residue. Purified water 
500.0 ml was added and pH was adjusted to 7.5-8.0 
using aquaeous ammonia under stirring. The mixture 
was extracted with dichloromethane. The combined 
organic extracts was dried over sodium sulfate, 
concentrated under vacuum to afford moxifloxacin 
base as a yellow powder.mp: 206-208 
o
C; 
1
H-NMR 
(500 MHz, DMSO-d6) δ (ppm): 8.62 (s, 1H, H-2); 
7.60 (d, J = 14.5 Hz, 1H, H-5); 4.12-4.10 (m, 1H, H-
13); 3.98-3.94 (m, 1H); 3.88-3.86 (m, 1H); 3.54 (s, 
3H, H-12); 3.37-3.23 (m, 3H); 2.88-2.86 (m, 1H); 
2.54-2.51(m, 1H); 2.24 (m, 1H); 1.73- 1.59 (m, 3H); 
1.41 (m, 1H); 1.21-1.17 (m, 1H); 1.13-1.08 (m, 1H); 
1.02-0.96 (m, 1H); 0.89-0.84 (m, 1H). 
13
C-NMR 
(125MHz, DMSO-d6) δ (ppm): 175.8; 165.9; 153.7; 
149.9; 140.2; 137.3; 134.5; 116.4; 106.3; 106.1; 
61.1; 58.5; 56.0; 52.1; 44.4; 40.6; 36.3; 22.9; 21.5; 
9.6; 8.1. ESI-MS m/z: [M-H]
-
: 400. 
 
 
 
3. RESULTS AND DISCUSSION 
 
We firstly started our study by the preparation of 
acetoxyboronate complex of fluoroquinoline 
ring.The reaction of boric acid with acetic anhydride 
formed the triacetoxyboronate, that was treated 
withethyll-cyclopropyl-6,7-difluoro-8-methoxy-4-
oxo-1,4-dihydro-3-quinoline carboxylate to produce 
the desired complex just for 2hrs [7]. Compared to 
the previous report of difluoroboron complex, that 
was obtained in 84% yield in 18 hrs reaction with 
BF3.Et2O [6], this method has many advantages.  
The reaction used low-cost reagents like boric acid 
and acetic anhydride, the complex  was obtained in a 
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better yield (96 %) than that of difluoroboron one 
and in a reduced time (only 2-3hrs).The 
1
H-NMR 
showed the signals of protons of fluoroquinolone 
ring at δH 9.19 (s, 1H,H-2), 8.07 (t, 1H, H-5), 4.38 
(m, 1H, N-CH) and 1.43-1.28 (m, 4H, CH2-
cyclopropyl ring). Moreover, a signal of two new 
acetyl groups attached to boron was found at δH 2.01 
ppm while the peak of ethyl ester group disappeared. 
The molecular ion peak [M+H]
+
 was found at 424 in 
the ESI-MS spectrum.Therefore, the 
acetoxyboronate complex structure was confirmed 
by the spectroscopy data. 
    Next, the condition of  the coupling reaction 
between the side chain amine and the 
acetoxyboronate complex was investigated. Like the 
difluoroboron complex, the side chain amine reacted 
regioselectively at C-7 position of the 
fluoroquinolinering. The solvents and the 
temperature of the reaction were varied. The results 
were shown in the table 1. 
 
Table 1: Yields of the coupling reaction at different 
conditions 
 
No Solvent 
Temp., 
o
C 
Time Yield, % 
1 MeCN 80 30 min 64.5 
2 MeOH 80 40 min 58.7 
3 EtOH 80 40 min 60.3 
4 Toluene 80 2 h 51.1 
5 MeCN 50 1 h 68.7 
6 MeCN 25 2.5 h 73.5 
 
Different solvents like MeOH, EtOH, 
acetonitrile and toluene was selected for the 
investigation. The reaction mixture of  the complex, 
amine and triethylamine was heated at 80
o
C. 
Reaction using acetonitrile as the solvent gave the 
best result, Moxifloxacin was obtained in 64.5 % 
yield. 
Then the temperature of the reaction using 
acetonitrile as the solvent was varied. At lower 
temperature, the reaction required longer time as 
expected but gave better yields. This result is 
consistent with our reported paper [6], the reaction 
of the acetoxyboronate complex using solvent 
acetonitrile and at room temperature afforded 
moxifloxacin base with highest yield of 73.5 %. The 
yield of this method is slightly higher than that of 
previous synthetic route using difluoroboron 
complex (67.8 %). The structure of Moxifloxacin 
was confirmed by IR, NMR and MS data and 
identical with the previously reported literature       
[6, 8]. 
 
4. CONCLUSION 
 
In summary, Moxifloxacin base was obtained 
from fluoroquinolinering via acetoxyboronate 
complex with 70 % overall yield. This method gave 
the desired moxifloxacin with better yield than that 
of difluoroboron complex (60 %). In adition, the 
preparation of the acetoxyboronate complex is more 
effective, using low-cost chemical reagents, a 
shorter time and better yield. This synthetic route 
was successfully applied to prepare Moxifloxacin in 
large scale. 
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